• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染儿童死亡时的特征:20世纪90年代的一项经验

Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s.

作者信息

Johann-Liang R, Cervia J S, Noel G J

机构信息

Division of Pediatric Infectious Diseases and Immunology, The New York Hospital-Cornell Medical Center, NY 10021, USA.

出版信息

Pediatr Infect Dis J. 1997 Dec;16(12):1145-50. doi: 10.1097/00006454-199712000-00009.

DOI:10.1097/00006454-199712000-00009
PMID:9427460
Abstract

OBJECTIVE

To describe the changes in the characteristics of human immunodeficiency virus (HIV)-related deaths in children with perinatally acquired infection.

METHODS

A retrospective review of all deaths that occurred in HIV-infected children managed at The New York Hospital-Program for Children with AIDS during a 7-year period from January, 1990, to December, 1996. Differences in the characteristics at death between 15 children who died in 1990 and 10 children who died in 1996 were analyzed.

RESULTS

Fifty-eight deaths in our cohort of HIV-infected children were identified during the 7-year period. The mean age at death was 4.43 years. Sixty-nine percent of children were black, 55% were male and 94% were receiving Medicaid. The mean weight/age Z score was -3.9 and the mean CD4 index was 0.067 with 65% having <50 CD4 cells/microl at the time of death (TOD). The most common organ/organ systems to be involved at the TOD were lung (78%) and central nervous system (61%). Mycobacterium avium complex (MAC) was the most common isolate at the TOD (26%) followed by Pneumocystis carinii (20%) and Pseudomonas aeruginosa (17%). The leading non-infectious cause of death was cardiac failure (9%). Comparison of the characteristics at the TOD between 1990 and 1996 revealed significant differences in mean age (2.1 vs. 9.2 years, P < 0.0001), mean CD4 count index (0.18 vs. 0.02, P < 0.03), mean number of organ/organ system involvement (3.9 vs. 5.9, P < 0.05), percent receiving antiretroviral therapy (33% vs. 70%, P < 0.02), mean number of years receiving antiretroviral therapy (0.88 vs. 3.86 years, P < 0.01), percent receiving P. carinii pneumonia prophylaxis (27% vs. 100%, P < 0.001), percent receiving MAC prophylaxis/therapy (0% vs. 100%, P < 0.0001), and cause of death from P. carinii pneumonia (53% vs. 0%, P < 0.01).

CONCLUSIONS

Compared with children who died in 1990, HIV-infected children who died in 1996 were significantly older, more lymphopenic and more likely to have a greater number of organ system involvements and to have received antiviral therapy and antimicrobial prophylaxis. In 1996 no child died of P. carinii pneumonia. In 1996 MAC and P. aeruginosa were the two most important opportunistic infections causing death. These changes in the characteristics at death will warrant review of resources used in treating these children and may be critical in advising parents and care givers about the prognosis of this chronic infection.

摘要

目的

描述围生期获得性感染儿童中与人类免疫缺陷病毒(HIV)相关死亡的特征变化。

方法

回顾性分析1990年1月至1996年12月这7年间在纽约医院儿童艾滋病项目中接受治疗的HIV感染儿童的所有死亡病例。分析了1990年死亡的15名儿童和1996年死亡的10名儿童在死亡特征方面的差异。

结果

在这7年间,我们队列中的HIV感染儿童共有58例死亡。平均死亡年龄为4.43岁。69%的儿童为黑人,55%为男性,94%接受医疗补助。平均体重/年龄Z评分为-3.9,平均CD4指数为0.067,65%的儿童在死亡时CD4细胞计数<50个/微升。死亡时最常受累的器官/器官系统是肺(78%)和中枢神经系统(61%)。鸟分枝杆菌复合体(MAC)是死亡时最常见的分离菌(26%),其次是卡氏肺孢子虫(20%)和铜绿假单胞菌(17%)。主要的非感染性死亡原因是心力衰竭(9%)。1990年和1996年死亡时特征的比较显示,平均年龄(2.1岁对9.2岁,P<0.0001)、平均CD4细胞计数指数(0.18对0.02,P<0.03)、平均受累器官/器官系统数量(3.9对5.9,P<0.05)、接受抗逆转录病毒治疗的百分比(33%对70%,P<0.02)、接受抗逆转录病毒治疗的平均年数(0.88年对3.86年,P<0.01)、接受卡氏肺孢子虫肺炎预防的百分比(27%对100%,P<0.001)、接受MAC预防/治疗的百分比(0%对100%,P<0.0001)以及死于卡氏肺孢子虫肺炎的原因(53%对0%,P<0.01)存在显著差异。

结论

与1990年死亡的儿童相比,1996年死亡的HIV感染儿童年龄显著更大、淋巴细胞减少更明显,更有可能出现更多器官系统受累,并且接受了抗病毒治疗和抗菌预防。1996年没有儿童死于卡氏肺孢子虫肺炎。1996年,MAC和铜绿假单胞菌是导致死亡的两个最重要的机会性感染。这些死亡特征的变化将有必要审查用于治疗这些儿童所使用的资源,并且对于向家长和护理人员提供有关这种慢性感染预后的建议可能至关重要。

相似文献

1
Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s.人类免疫缺陷病毒感染儿童死亡时的特征:20世纪90年代的一项经验
Pediatr Infect Dis J. 1997 Dec;16(12):1145-50. doi: 10.1097/00006454-199712000-00009.
2
Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.112名感染人类免疫缺陷病毒的婴儿队列中,18个月龄前进行初级预防在降低卡氏肺孢子虫肺炎发病率和早期死亡方面的益处。纽约市围产期HIV传播协作研究组。
Pediatrics. 1996 Jan;97(1):59-64.
3
Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.美国围产期获得性人类免疫缺陷病毒感染儿童中卡氏肺孢子虫肺炎的预防。卡氏肺孢子虫肺炎预防评估工作组。
N Engl J Med. 1995 Mar 23;332(12):786-90. doi: 10.1056/NEJM199503233321206.
4
Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.预测人类免疫缺陷病毒感染儿童患卡氏肺孢子虫肺炎的风险。
Am J Dis Child. 1991 Aug;145(8):922-4. doi: 10.1001/archpedi.1991.02160080100028.
5
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.一项关于HIV感染患者接受高效抗逆转录病毒治疗后停止卡氏肺孢子虫肺炎一级和二级预防的随机试验。艾滋病研究小组04/98。
N Engl J Med. 2001 Jan 18;344(3):159-67. doi: 10.1056/NEJM200101183440301.
6
Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯市人类免疫缺陷病毒1型感染儿童的临床和流行病学特征
Int J Infect Dis. 2002 Mar;6(1):9-16. doi: 10.1016/s1201-9712(02)90129-3.
7
Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.在高效抗逆转录病毒治疗之前接受管理的感染人类免疫缺陷病毒的儿童中机会性感染的相关因素
Pediatr Infect Dis J. 2001 Jan;20(1):40-8. doi: 10.1097/00006454-200101000-00008.
8
1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.1995年修订的针对感染人类免疫缺陷病毒或在围产期接触过该病毒的儿童预防卡氏肺孢子虫肺炎的指南。国家儿科和家庭艾滋病毒资源中心以及疾病控制和预防中心国家传染病中心
MMWR Recomm Rep. 1995 Apr 28;44(RR-4):1-11.
9
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.对接受抗逆转录病毒治疗有反应的HIV感染患者停止卡氏肺孢子虫肺炎的二级预防。八个欧洲研究小组。
N Engl J Med. 2001 Jan 18;344(3):168-74. doi: 10.1056/NEJM200101183440302.
10
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.接受化疗治疗的人类免疫缺陷病毒相关非霍奇金淋巴瘤患者的机会性感染与免疫功能
J Natl Cancer Inst. 1997 Feb 19;89(4):301-7. doi: 10.1093/jnci/89.4.301.

引用本文的文献

1
Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.了解常见儿童疾病和机会性感染对资源有限环境中感染 HIV 的儿童发病率和死亡率的影响。
AIDS. 2013 Nov;27 Suppl 2(0 2):S159-67. doi: 10.1097/QAD.0000000000000080.
2
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.高效抗逆转录病毒疗法对 HIV-1 围生期感染儿童和青少年心肌病的影响。
AIDS. 2012 Oct 23;26(16):2027-37. doi: 10.1097/QAD.0b013e3283578bfa.
3
Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
美国围产期艾滋病合作传播研究(1986-2004)中的死亡率趋势。
Clin Infect Dis. 2011 Nov;53(10):1024-34. doi: 10.1093/cid/cir641.
4
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.抗逆转录病毒治疗时代 HIV-1 感染儿童死亡率的下降和死亡原因的变化。
J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94. doi: 10.1097/QAI.0b013e3181b9869f.
5
Reporting of deaths during pre-approval clinical trials for advanced HIV-infected populations.
Drug Saf. 2005;28(7):559-64. doi: 10.2165/00002018-200528070-00001.
6
Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study.人类免疫缺陷病毒感染儿童心脏异常的发生率:前瞻性P2C2 HIV研究。
J Pediatr. 2002 Sep;141(3):327-34. doi: 10.1067/mpd.2002.126301.
7
The role of protease inhibitor therapy in children with HIV infection.蛋白酶抑制剂疗法在感染艾滋病毒儿童中的作用。
Paediatr Drugs. 2002;4(9):581-607. doi: 10.2165/00128072-200204090-00004.
8
Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study.婴幼儿与儿童中与人类免疫缺陷病毒相关的死亡率:来自垂直传播的HIV的儿科肺部和心血管并发症(P(2)C(2))研究的数据
Pediatrics. 2001 Feb;107(2):328-38. doi: 10.1542/peds.107.2.328.
9
Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.艾滋病患者的假单胞菌属并发症:一项为期八年的临床与微生物学调查。
Eur J Epidemiol. 2000 Feb;16(2):111-8. doi: 10.1023/a:1007626410724.